(+)-Matrine
CAS No. 519-02-8
(+)-Matrine( NSC 146051 | NSC 318810 )
Catalog No. M14816 CAS No. 519-02-8
Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 32 | Get Quote |
|
| 50MG | 48 | Get Quote |
|
| 100MG | 67 | Get Quote |
|
| 500MG | 237 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(+)-Matrine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMatrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
-
DescriptionMatrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
-
In VitroCell Viability Assay Cell Line:A549, SMMC-7721 cells Concentration:0-500 μg/mL for A549 cells, 0-1.5 mg/mL for SMMC-7721 cellsIncubation Time:24-72 h Result:Inhibited the growth of A549 and SMMC-7721 cells.Western Blot AnalysisCell Line:A549, SMMC-7721 cells Concentration:100-250 μg/mL for A549 cells, 0.5-1 mg/mL for SMMC-7721 cellsIncubation Time:24 h Result:Down-regulated the expression of anti-apoptotic protein (Bcl-2) and up-regulated the level of pro-apoptotic protein (bax).ImmunofluorescenceCell Line:HK2 cells Concentration:10 μM Incubation Time:48 h Result:Increased SIRT3 expression reduced under cisplatin stimuli.
-
In VivoAnimal Model:Xenograft male C57BL/6mice model (LLC cells)Dosage:40 and 80 mg/kg for 16 consecutive days Administration:Intragastric administration Result:Inhibited tumors growth.Decreased the ratio of CD206+/F4/80+, promoted the expression of CD4+ and CD8+ T cells, and inhibited the expression of Th2 in tumor and spleen tissues. Animal Model:Cisplatin-induced acute kidney injury (AKI) mice model Dosage:5 mg/kg daily for 4 days Administration:Intraperitoneal injections Result:Attenuated tubular injury observed in AKI mice, including renal tubular necrosis,formation of tubular casts, cytoplasmic vacuoles and renal infiltrationof inflammatory cells in mice.Decreased serum levels of TNF-a and IL-6 and the phosphorylation of NF-κB, activated SIRT3/OPA1 axis and improved mitochondrial function.
-
SynonymsNSC 146051 | NSC 318810
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
Recptorκ-opioid receptor
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number519-02-8
-
Formula Weight248.37
-
Molecular FormulaC15H24N2O
-
Purity>98% (HPLC)
-
SolubilityEthanol: 49 mg/mL (197.29 mM); Water: 11 mg/mL warmed (44.29 mM); DMSO: 49 mg/mL (197.29 mM)
-
SMILESO=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@H]([C@@H]34)CN12
-
Chemical Name(41S,7aS,13aR,13bR)-dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ren H, et al. Acta Biochim Biophys Sin (Shanghai). 2014 Dec;46(12):1049-55.
molnova catalog
related products
-
SCH 221510
SCH 221510 is an orally available, selective and potent NOP agonist with an EC50 of 12 nM and a Ki of 0.3 nM.SCH 221510 has anxiolytic activity and can be used to study neurological disorders.
-
CTAP
Potent and selective μ opioid receptor antagonist (IC50 = 3.5 nM). Displays > 1200-fold selectivity over δ opioid and somatostatin receptors. Brain penetrant and active in vivo.
-
Ac-RYYRWK-NH2
Potent, selective partial agonist peptide for the NOP receptor (Ki = 0.71 nM). Selective over μ, δ and κ opioid receptors (IC50 > 4000 nM). Increases food intake in vivo.
Cart
sales@molnova.com